Healthcare Industry
Filter News
Found 14,274 articles
-
With the Thanksgiving holiday upon us, BioSpace felt it was important to give thanks for some of the positive things that have happened this year. And there are many!
-
Although vaccines and effective therapeutics are powerful tools in preventing and treating COVID-19, we’re not done battling the disease just yet. For those stories and more, read on.
-
Philips collaborates with leading institutes to bring its breakthrough spectral CT imaging into the interventional suite
11/24/2021
Philips showcases world’s first spectral detector angio-CT solution at RSNA 2021.
-
Johnson & Johnson COVID-19 Vaccine Fully Approved by Health Canada to Prevent COVID-19 in Individuals 18 years and Older
11/24/2021
Vaccine demonstrates protection against COVID-19 related hospitalization and death, and across different variants.
-
Relief Reports that its U.S. Collaboration Partner has Announced the U.S. Food and Drug Administration has Denied Breakthrough Designation for Aviptadil
11/24/2021
RELIEF THERAPEUTICS Holding SA, a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported that the parent company of its collaboration partner, NRx Pharmaceuticals, Inc., has issued a CEO Update announcing that the U.S. Food and Drug Administration has denied Breakthrough Therapy Designation for aviptadil.
-
COVID-19 Fallout May Lead to More Cancer Deaths
11/24/2021
Significant decreases in CT imaging for cancer persisted even after the peak of the COVID-19 pandemic in 2020, delaying diagnosis and treatment and raising the possibility of more advanced cancers and poorer outcomes for patients in the future, according to a study being presented next week at the annual meeting of the Radiological Society of North America.
-
Next-generation Precision Medicine Company Allorion Therapeutics Completes Series A Financing Round
11/24/2021
Allorion Therapeutics, a company focusing on next-generation precision medicine for oncology and autoimmune disease, announced the completion of $40M Series A financing.
-
Selvita Group reports a dynamic increase in revenues for Q3 2021 YTD
11/24/2021
Selvita – one of the largest preclinical contract research organizations in Europe continues its dynamic development. Following the acquisition of Fidelta, Selvita Group achieved in the three quarters of 2021 over a two-fold increase in sales revenue comparing to the corresponding period of the previous year.
-
Relief Therapeutics and InveniAI Sign a Strategic Collaboration Agreement to Identify New Product Development Opportunities using Artificial Intelligence
11/24/2021
RELIEF THERAPEUTICS Holding SA, announced that it has signed a collaboration agreement with InveniAI LLC, a U.S. based company that has pioneered the application of artificial intelligence and machine learning across biopharma and other industries, in order to identify promising drug candidates to treat rare and specialty diseases.
-
Amgen To Present At The 2021 Piper Sandler Healthcare Conference
11/24/2021
Amgen (NASDAQ:AMGN) will present at the 2021 Piper Sandler Healthcare Conference at 1:00 p.m. ET on Wednesday, Dec. 1, 2021.
-
Amgen To Present At The 2021 Evercore ISI Healthcare Conference
11/24/2021
Amgen (NASDAQ:AMGN) will present at the 2021 Evercore ISI Healthcare Conference at 5:10 p.m. ET on Tuesday, Nov. 30, 2021. Rob Lenz, M.D., Ph.D., senior vice president of Global Development at Amgen will present at the conference.
-
Kura Oncology to Participate in Two Upcoming Investor Conferences - Nov 23, 2021
11/23/2021
Kura Oncology, Inc., a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in two upcoming virtual investor conferences.
-
IceCure Medical Reports Financial Results as of and for the first Nine Months of 2021 and Recent Corporate Developments
11/23/2021
IceCure Medical Ltd., developer of next-generation, minimally-invasive cryoablation technology with ProSense® that destroys tumors by freezing as an alternative to surgical tumor removal, reported its financial results as of and for the nine-month period ended September 30, 2021.
-
Canon Medical’s All-New 12”×16” High-Definition (Hi-Def) Imaging Detector Provides Highest Resolution in the Market to Help Clinicians See Fine Details
11/23/2021
Canon Medical Systems Corporation is introducing an all-new size for its Hi-Def flat panel detector.
-
Tauriga Sciences, Inc. Announces Results of Special Meeting of Shareholders Held on November 22, 2021
11/23/2021
Tauriga Sciences, Inc., a New York based diversified Life Sciences Company, announced the results of its Special Meeting of stockholders held at 9:00am EST on November 22, 2021.
-
Paragon Launches Strings, a New Managed Service for Enterprise Imaging Analytics and Performance Optimization
11/23/2021
Paragon Consulting Partners, LLC today announces the launch of Strings by Paragon (Strings), a fully managed, vendor agnostic analytics solution for real-time enterprise imaging clinical workflow and applications monitoring.
-
Autism Changes Brain's White Matter over Time
11/23/2021
Researchers at Yale University analyzing specialized MRI exams found significant changes in the microstructure of the brain's white matter in adolescents and young adults with autism spectrum disorder compared to a control group, according to research being presented next week at the annual meeting of the Radiological Society of North America.
-
Cooled RFA Relieves Pain after Knee Replacement
11/23/2021
A minimally invasive ablation procedure offers long-term relief for patients who experience chronic and debilitating pain after knee replacement surgery, according to a study being presented next week at the annual meeting of the Radiological Society of North America.
-
iOnctura to Share Clinical and Preclinical Data on IOA-244 and IOA-289 at ESMO-IO in December 2021
11/23/2021
iOnctura SA, a clinical stage oncology company targeting core resistance and relapse mechanisms at the tumor-stroma-immune interface, announces it will present clinical and preclinical data on two pipeline assets, IOA-244 and IOA-289, at the European Society of Medical Oncology’s Immuno-Oncology Congress taking place on December 8–11, 2021 in Geneva, Switzerland and virtually.
-
Flywheel Partners with Roche and Genentech to Accelerate Development of Personalized Healthcare Solutions
11/22/2021
Flywheel , the leading cloud-scale informatics platform for biomedical research and collaboration, announced today the successful integration of its platform by Roche and Genentech, a member of the Roche Group, for ingestion, classification, standardization, curation and analysis of medical imaging data.